Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
- PMID: 33454844
- PMCID: PMC7897189
- DOI: 10.1007/s10555-021-09955-5
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
Erratum in
-
Correction to: Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?Cancer Metastasis Rev. 2024 Jun;43(2):845. doi: 10.1007/s10555-021-09966-2. Cancer Metastasis Rev. 2024. PMID: 33860435 No abstract available.
References
-
- Seo EJ, Kwon YW, Jang IH, Kim DK, Lee SI, Choi EJ, Kim KH, Suh DS, Lee JH, Choi KU, Lee JW, Mok HJ, Kim KP, Matsumoto H, Aoki J, Kim JH. Autotaxin regulates maintenance of ovarian cancer stem cells through lysophosphatidic acid-mediated autocrine mechanism. Stem Cells. 2016;34(3):551–564. doi: 10.1002/stem.2279. - DOI - PubMed
-
- Leblanc R, Lee SC, David M, Bordet JC, Norman DD, Patil R, Miller D, Sahay D, Ribeiro J, Clézardin P, Tigyi GJ, Peyruchaud O. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood. 2014;124(20):3141–3150. doi: 10.1182/blood-2014-04-568683. - DOI - PMC - PubMed
-
- Auciello FR, Bulusu V, Oon C, Tait-Mulder J, Berry M, Bhattacharyya S, Tumanov S, Allen-Petersen BL, Link J, Kendsersky ND, Vringer E, Schug M, Novo D, Hwang RF, Evans RM, Nixon C, Dorrell C, Morton JP, Norman JC, Sears RC, Kamphorst JJ, Sherman MH. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discovery. 2019;9(5):617–627. doi: 10.1158/2159-8290.Cd-18-1212. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
